Cargando…
Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB(1) activation
AIMS: The protective effects of cannabidiol (CBD) have been widely shown in preclinical models and have translated into medicines for the treatment of multiple sclerosis and epilepsy. However, the direct vascular effects of CBD in humans are unknown. METHODS AND RESULTS: Using wire myography, the va...
Autores principales: | Stanley, Christopher P., Hind, William H., Tufarelli, Cristina, O'Sullivan, Saoirse E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540144/ https://www.ncbi.nlm.nih.gov/pubmed/26092099 http://dx.doi.org/10.1093/cvr/cvv179 |
Ejemplares similares
-
The endocannabinoid anandamide causes endothelium-dependent vasorelaxation in human mesenteric arteries
por: Stanley, Christopher P., et al.
Publicado: (2016) -
In Vivo Cannabidiol Treatment Improves Endothelium-Dependent Vasorelaxation in Mesenteric Arteries of Zucker Diabetic Fatty Rats
por: Wheal, Amanda J., et al.
Publicado: (2017) -
Cyclooxygenase metabolism mediates vasorelaxation to 2-arachidonoylglycerol (2-AG) in human mesenteric arteries
por: Stanley, Christopher P., et al.
Publicado: (2014) -
Ovariectomy-Induced Reductions in Endothelial SK3 Channel Activity and Endothelium-Dependent Vasorelaxation in Murine Mesenteric Arteries
por: Yap, Fui C., et al.
Publicado: (2014) -
Hydrogen Sulfide and Endothelium-Dependent Vasorelaxation
por: Bełtowski, Jerzy, et al.
Publicado: (2014)